To further investigate the differences in somatic mutation frequency between the two subgroups, we analyzed genes with high mutation frequency or in important pathways relevant to HCC, including P53, cell cycle pathway, WNT beta-catenin pathway, and hepatic differentiation. This evidence concerns the gene TP53 and hepatocellular carcinoma.